Monigen Xl (Isosorbide Mononitrate)

Isosorbide Mononitrate belongs to the organic nitrate class and is employed in the management of coronary artery disease‑related chest pain.

• Stable angina: reduces the frequency and severity of angina attacks.
• Chronic angina: provides sustained relief for patients with long‑term chest pain.
• Angina prophylaxis: helps prevent episodes of chest discomfort during physical exertion.

• Isosorbide Mononitrate is metabolized to release nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting increase in cyclic GMP causes relaxation of both venous and arterial vessels, lowering preload and afterload and improving myocardial oxygen delivery while reducing cardiac workload.

Isosorbide Mononitrate may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects

• Headache: mild to moderate, often transient.
• Dizziness or light‑headedness, especially on standing.
• Flushing: warm sensation with reddening of skin.
• Nausea or upset stomach.
• Palpitations: awareness of heartbeat.
• Fatigue: generalized tiredness.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure.
• Syncope: fainting episodes.
• Allergic reactions: rash, itching, swelling.
• Methemoglobinemia: abnormal hemoglobin levels.
• Persistent tachycardia: rapid heart rate.
• Chest pain worsening: paradoxical increase in angina.

Before initiating therapy, clinicians should assess individual risk factors and comorbidities.

• Cardiovascular assessment: evaluate blood pressure and heart rate.
• Concomitant nitrates: avoid combined use to prevent severe hypotension.
• Phosphodiesterase‑5 inhibitors: assess timing to reduce interaction risk.
• Renal or hepatic impairment: adjust monitoring as needed.
• Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Isosorbide Mononitrate can interact with several drug classes, influencing its safety profile.

Major Interactions (Avoid)

• Other organic nitrates or nitroglycerin: additive vasodilatory effect leading to profound hypotension.
• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe blood pressure fall.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents (ACE inhibitors, beta‑blockers): may enhance blood pressure lowering.
• Diuretics: can potentiate orthostatic hypotension.
• Alcohol: may increase vasodilatory side effects.
• Certain antacids: may affect absorption, monitor therapeutic response.